Denali Advisors’s Crescent Capital BDC CCAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.06M Sell
96,746
-4,941
-5% -$60.3K 0.11% 184
2026
Q1
$1.24M Buy
101,687
+842
+0.8% +$11.5K 0.14% 160
2025
Q4
$1.42M Sell
100,845
-16,588
-14% -$236K 0.16% 139
2025
Q3
$1.67M Sell
117,433
-36,258
-24% -$543K 0.19% 126
2025
Q2
$2.17M Sell
153,691
-24,894
-14% -$382K 0.23% 116
2025
Q1
$3.06M Sell
178,585
-5,198
-3% -$96.8K 0.35% 89
2024
Q4
$3.53M Buy
183,783
+855
+0.5% +$16.2K 0.37% 92
2024
Q3
$3.38M Buy
+182,928
New +$3.4M 0.36% 95

Other funds holding CCAP

Denali Advisors's CCAP Position: Q2 2026 in Review

Denali Advisors reduced its Crescent Capital BDC (CCAP) stake by 4.9% in Q2 2026, selling an estimated $60.3K and leaving 96,746 shares worth $1.06M. The position accounts for 0.11% of the portfolio, ranked #184.

Denali Advisors first reported a position in CCAP in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.53M in Q4 2024. 85 funds tracked by Wall St. Rank hold CCAP as of Q2 2026.

  • Denali Advisors held 96,746 shares of Crescent Capital BDC worth $1.06M as of Q2 2026.
  • Denali Advisors sold 4,941 Crescent Capital BDC shares in Q2 2026, an estimated $60.3K.
  • Crescent Capital BDC made up 0.11% of Denali Advisors's portfolio in Q2 2026, its #184 holding.
  • Denali Advisors first reported a position in Crescent Capital BDC in Q3 2024 and has held it in 8 quarters since.
  • Denali Advisors's Crescent Capital BDC position peaked at $3.53M in Q4 2024.
  • 85 funds tracked by Wall St. Rank held Crescent Capital BDC as of Q2 2026.

Based on Denali Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.